MILabs launches new E-Class line of tomographic imaging products

NewsGuard 100/100 Score

Continuing its customer-centric approach, and fulfilling its commitment to providing preclinical imaging systems of unmatched price/performance, MILabs has introduced its E-Class of tomographic imaging products. The E-Class imagers were specifically designed for ambitious researchers to start their research now, and who want the option to easily upgrade the same system in the future.

We have an exciting new range of E-class products in our portfolio, and these high-performance, modular, standalone, and integrated imagers are economical, exceptional and field-expandable. We are enabling the cost-saving aspects by these entry level imaging systems, and we are confident that our global prospects will be enthusiastic that the E-Class PET, SPECT and CT systems are available today and can be upgraded later. With these new products, we are continuing our brand promise of “making molecular imaging clear” for all preclinical researchers.

Prof. Frederik Beekman, CEO of MILabs.

The E-Class systems were developed using the same advanced imaging technologies as the industry-leading VECTor system, and refined for lower cost and easy scalability.

The E-Class systems were built for the future needs of researchers, so they can start small, think big and scale fast.

Prof. Frederik Beekman, CEO of MILabs.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Revolutionizing brain tumor treatment: the rise of AI in neuro-oncology